[
  {
    "ts": null,
    "headline": "How Recent Developments Are Reshaping The UnitedHealth Group Investment Story",
    "summary": "UnitedHealth Group's fair value estimate has inched higher to about $388.52 as analysts grow more confident that the current earnings trough will give way to stronger growth in the coming years. This modest upward shift reflects improving visibility around margin recovery in key businesses like Medicare Advantage and Medicaid, supported by better star ratings, disciplined repricing, and strategic restructuring at Optum. Stay tuned to learn how you can monitor these evolving analyst targets...",
    "url": "https://finnhub.io/api/news?id=5a6f0aec8c6d1a977359f8990b85c9ada8d78e7c00dfe8f23140ecdc49143c4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765105780,
      "headline": "How Recent Developments Are Reshaping The UnitedHealth Group Investment Story",
      "id": 137726416,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "UnitedHealth Group's fair value estimate has inched higher to about $388.52 as analysts grow more confident that the current earnings trough will give way to stronger growth in the coming years. This modest upward shift reflects improving visibility around margin recovery in key businesses like Medicare Advantage and Medicaid, supported by better star ratings, disciplined repricing, and strategic restructuring at Optum. Stay tuned to learn how you can monitor these evolving analyst targets...",
      "url": "https://finnhub.io/api/news?id=5a6f0aec8c6d1a977359f8990b85c9ada8d78e7c00dfe8f23140ecdc49143c4e"
    }
  },
  {
    "ts": null,
    "headline": "Why The Narrative Around Gilead Sciences Is Shifting After HIV And Oncology Updates",
    "summary": "Gilead Sciences stock has seen its fair value estimate edge down only slightly, from about $130.83 to $130.63, even as the discount rate nudged up from roughly 7.26% to 7.29% and long term revenue growth expectations eased from around 3.89% to 3.68%. These modest adjustments reflect analysts fine tuning their models in light of a more nuanced mix of tailwinds, such as extended HIV cash flows and a larger PrEP opportunity, and headwinds, such as execution risk in next generation programs and...",
    "url": "https://finnhub.io/api/news?id=676ca898fdc9947205c4e4805aaa7371942915759f2c6305e75e28691b17eeaf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765095032,
      "headline": "Why The Narrative Around Gilead Sciences Is Shifting After HIV And Oncology Updates",
      "id": 137726492,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Gilead Sciences stock has seen its fair value estimate edge down only slightly, from about $130.83 to $130.63, even as the discount rate nudged up from roughly 7.26% to 7.29% and long term revenue growth expectations eased from around 3.89% to 3.68%. These modest adjustments reflect analysts fine tuning their models in light of a more nuanced mix of tailwinds, such as extended HIV cash flows and a larger PrEP opportunity, and headwinds, such as execution risk in next generation programs and...",
      "url": "https://finnhub.io/api/news?id=676ca898fdc9947205c4e4805aaa7371942915759f2c6305e75e28691b17eeaf"
    }
  },
  {
    "ts": null,
    "headline": "What The Evolving Market Narrative Means For MTN Group's Valuation",
    "summary": "MTN Group’s fair value estimate has inched up to about $176.89 from $172.50, even as expected revenue growth is nudged slightly lower and the discount rate holds steady at 16.73%. This subtle recalibration reflects how markets are increasingly rewarding clear execution and credible long term plans over short term headline numbers. Stay tuned to see how you can track these evolving valuation signals and follow the changing MTN Group narrative. Analyst Price Targets don't always capture the...",
    "url": "https://finnhub.io/api/news?id=f0a6c5e6173b215dea6810ba4deb36e6a11d075ff5f6d3a735b675c51cdd65ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765094995,
      "headline": "What The Evolving Market Narrative Means For MTN Group's Valuation",
      "id": 137726619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "MTN Group’s fair value estimate has inched up to about $176.89 from $172.50, even as expected revenue growth is nudged slightly lower and the discount rate holds steady at 16.73%. This subtle recalibration reflects how markets are increasingly rewarding clear execution and credible long term plans over short term headline numbers. Stay tuned to see how you can track these evolving valuation signals and follow the changing MTN Group narrative. Analyst Price Targets don't always capture the...",
      "url": "https://finnhub.io/api/news?id=f0a6c5e6173b215dea6810ba4deb36e6a11d075ff5f6d3a735b675c51cdd65ee"
    }
  },
  {
    "ts": null,
    "headline": "What Analysts Think Is Changing the Story for Marriott Vacations Worldwide",
    "summary": "Marriott Vacations Worldwide has seen its fair value estimate trimmed from about $68 to roughly $64 per share as analysts recalibrate expectations for the company’s growth trajectory. With the discount rate steady at 12.5% and revenue growth assumptions nudged down from roughly 23.2% to about 22.2%, the latest reset reflects a more cautious but still constructive view amid operational and leadership transitions. Read on to see how this evolving narrative could influence future valuations and...",
    "url": "https://finnhub.io/api/news?id=6052144795390fe1e6cd8bf2ac816634c573550658f2172d2fd7e0f3c654cf5a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765083901,
      "headline": "What Analysts Think Is Changing the Story for Marriott Vacations Worldwide",
      "id": 137726620,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Marriott Vacations Worldwide has seen its fair value estimate trimmed from about $68 to roughly $64 per share as analysts recalibrate expectations for the company’s growth trajectory. With the discount rate steady at 12.5% and revenue growth assumptions nudged down from roughly 23.2% to about 22.2%, the latest reset reflects a more cautious but still constructive view amid operational and leadership transitions. Read on to see how this evolving narrative could influence future valuations and...",
      "url": "https://finnhub.io/api/news?id=6052144795390fe1e6cd8bf2ac816634c573550658f2172d2fd7e0f3c654cf5a"
    }
  }
]